Cargando…
Influence of safety warnings on ESA prescribing among dialysis patients using an interrupted time series
BACKGROUND: In March, 2007, a black box warning was issued by the Food and Drug Administration (FDA) to use the lowest possible erythropoiesis-stimulating agents (ESA) doses for treatment of anemia associated with renal disease. The goal is to determine if a change in ESA use was observed following...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751481/ https://www.ncbi.nlm.nih.gov/pubmed/23927675 http://dx.doi.org/10.1186/1471-2369-14-172 |